96 related articles for article (PubMed ID: 10838527)
1. Prognostic value of the quantified expression of p185 in non-small cell lung cancer.
Cantero R; Torres AJ; Maestro ML; Hernando F; Sanz MT; Del Barco V; Gómez A; Fernández C; Balibrea JL
J Thorac Cardiovasc Surg; 2000 Jun; 119(6):1119-25. PubMed ID: 10838527
[TBL] [Abstract][Full Text] [Related]
2. Use of possible synergistic expression of p53 and p185 as a prognostic tool for stage I non-small-cell lung cancer.
Cantero R; Torres AJ; Maestro M; Fernández C; Hernando F; del Barco V; Sanz T; Balibrea JL
World J Surg; 1999 Dec; 23(12):1294-9; discussion 1299-300. PubMed ID: 10552124
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer.
Shi D; He G; Cao S; Pan W; Zhang HZ; Yu D; Hung MC
Mol Carcinog; 1992; 5(3):213-8. PubMed ID: 1350198
[TBL] [Abstract][Full Text] [Related]
4. Prediction of recurrence by quantification of p185neu protein in non-small-cell lung cancer tissue.
Diez M; Pollán M; Maestro M; Torres A; Ortega D; Gómez A; Sánchez A; Hernando F; Balibrea JL
Br J Cancer; 1997; 75(5):684-9. PubMed ID: 9043025
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells.
Tsai CM; Levitzki A; Wu LH; Chang KT; Cheng CC; Gazit A; Perng RP
Cancer Res; 1996 Mar; 56(5):1068-74. PubMed ID: 8640763
[TBL] [Abstract][Full Text] [Related]
6. p185(HER-2/neu) and p21(CIP1/WAF1) expression in primary tumors and lymph node metastases in non-small cell lung cancer.
Akita K; Inagaki H; Sato S; Niimi T; Maeda H; Ninomiya S; Achiwa H; Kawaguchi H; Yamakawa Y; Fujii Y; Shimizu S; Eimoto T; Ueda R
Jpn J Cancer Res; 2002 Sep; 93(9):1007-11. PubMed ID: 12359054
[TBL] [Abstract][Full Text] [Related]
7. [Study of the expression of proliferating cell nuclear antigen and p185 in non-small cell lung carcinoma].
Alemany Monraval P; Martorell Cebollada M; Salvador Villalba I; Martínez Leandro E
Arch Bronconeumol; 1996 Apr; 32(4):165-9. PubMed ID: 8689012
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.
Han H; Landreneau RJ; Santucci TS; Tung MY; Macherey RS; Shackney SE; Sturgis CD; Raab SS; Silverman JF
Hum Pathol; 2002 Jan; 33(1):105-10. PubMed ID: 11823980
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung.
Nemunaitis J; Klemow S; Tong A; Courtney A; Johnston W; Mack M; Taylor W; Solano M; Stone M; Mallams J; Mues G
Am J Clin Oncol; 1998 Apr; 21(2):155-60. PubMed ID: 9537203
[TBL] [Abstract][Full Text] [Related]
10. HER-2/neu oncogene and estrogen receptor expression in non small cell lung cancer patients.
Alerić I; Razumović JJ; Koprivica B
Med Pregl; 2012; 65(5-6):210-5. PubMed ID: 22730705
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of expression of FASE, HER-2/neu, bcl-2 and p53 in stage I non-small cell lung cancer].
Wang Y; Zhang XR; Fu J; Tan W; Zhang W
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):369-72. PubMed ID: 15312350
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of the quantitative measurement of the oncoprotein p185(Her-2/neu) in a group of patients with breast cancer and positive node involvement.
Bohn U; Aguiar J; Bilbao C; Murias A; Vega V; Chirino R; Díaz-Chico N; Díaz-Chico JC
Int J Cancer; 2002 Oct; 101(6):539-44. PubMed ID: 12237894
[TBL] [Abstract][Full Text] [Related]
13. Sequence-dependent enhancement of paclitaxel toxicity in non-small cell lung cancer by 17-allylamino 17-demethoxygeldanamycin.
Nguyen DM; Chen A; Mixon A; Schrump DS
J Thorac Cardiovasc Surg; 1999 Nov; 118(5):908-15. PubMed ID: 10534697
[TBL] [Abstract][Full Text] [Related]
14. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
Ardizzoni A; Cafferata MA; Paganuzzi M; Filiberti R; Marroni P; Neri M; Fontana V; Nicoló G; Perdelli L; Stampino CG; Rosso R; Puntoni R
Cancer; 2001 Oct; 92(7):1896-904. PubMed ID: 11745263
[TBL] [Abstract][Full Text] [Related]
15. HER-2/neu overexpression in patients with radically resected nonsmall cell lung carcinoma. Impact on long-term survival.
Selvaggi G; Scagliotti GV; Torri V; Novello S; Leonardo E; Cappia S; Mossetti C; Ardissone F; Lausi P; Borasio P
Cancer; 2002 May; 94(10):2669-74. PubMed ID: 12173335
[TBL] [Abstract][Full Text] [Related]
16. Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer.
Schneider PM; Praeuer HW; Stoeltzing O; Boehm J; Manning J; Metzger R; Fink U; Wegerer S; Hoelscher AH; Roth JA
Br J Cancer; 2000 Aug; 83(4):473-9. PubMed ID: 10945494
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the p185 protein in colorectal cancer.
Sanz-Casla MT; Vidaurreta M; Maestro ML; López JA; Jiménez F; Fernández C; Maestro C; Balibrea JL; Cerdán FJ
Rev Esp Enferm Dig; 2004 Feb; 96(2):102-9. PubMed ID: 15255019
[TBL] [Abstract][Full Text] [Related]
18. [P185 (Neu) oncoprotein in the prognosis of bladder carcinoma. Experience of 5 years].
Moreno Sierra J; Maestro de las Casas ML; Redondo González E; Fernández Pérez C; del Barco Barriuso V; Sanz Casla MT; Blanco Jiménez E; Silmi Moyano A; Resel Estévez L
Arch Esp Urol; 2000 Apr; 53(3):238-44. PubMed ID: 10851729
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of HER-2/neu protein concentration in breast cancer by enzyme-linked immunosorbent assay.
Müller V; Thomssen C; Karakas C; Eustermann I; Ramirez Porras J; Coith C; Berger J; Löning T; Jänicke F; Pantel K
Int J Biol Markers; 2003; 18(1):13-20. PubMed ID: 12699058
[TBL] [Abstract][Full Text] [Related]
20. p185(neu) protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma.
Nanni P; Pupa SM; Nicoletti G; De Giovanni C; Landuzzi L; Rossi I; Astolfi A; Ricci C; De Vecchi R; Invernizzi AM; Di Carlo E; Musiani P; Forni G; Menard S; Lollini PL
Int J Cancer; 2000 Jul; 87(2):186-94. PubMed ID: 10861472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
